I have a couple of questions sub1we,
1/ Where are the Smith and Nephew trials at and does Polynovo expect an outcome from this? if not then can we go elsewhere with this product, or is it still tied up with the military (DARPA) program and that is what is holding it up?
2/ Is Polynovo looking at something like what the Monash Uni are doing with stem cell growth in the epi dermis by also using BTM where it may be incorporated into the same operation to replace the dermis in one go, are they aware of this? and if so, is there any connection with Monash or any other hospital in this area?
Alan Kohler/Paul Brennan Interview - 19.10.2017, page-54
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.49 |
Change
-0.100(3.86%) |
Mkt cap ! $1.715B | |||
| Open | High | Low | Value | Volume |
| $2.58 | $2.58 | $2.47 | $1.986M | 786.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 27625 | $2.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.49 | 17579 | 26 |
View Market Depth
| Last trade - 13.03pm 18/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |